Atlanta, GA – August 16, 2024

On January 19, 2024, the Mark Cuban Cost Plus Drug Company (MCCPDC) officially launched its much-anticipated online pharmacy. The company aims to disrupt the pharmaceutical industry by offering significant savings on prescription medications. As a registered pharmaceutical wholesaler, MCCPDC is uniquely positioned to bypass traditional middlemen and eliminate the excessive markups often associated with prescription drugs.

The company’s business model is straightforward. MCCPDC’s online pharmacy offers a wide range of generic medications at steep discounts. For instance, commonly prescribed drugs such as fluoxetine (for depression) and lisinopril (for high blood pressure) are available at a fixed markup of just 15% plus a $3 flat fee. Notably, MCCPDC does not offer brand-name drugs and does not accept insurance, meaning patients pay for their medications out of pocket. However, the cost savings are significant enough that many patients may find the out-of-pocket expenses lower than their insurance co-pays and deductibles.

In its press release, MCCPDC highlighted several medications, showcasing its commitment to affordability. For example, Imatinib, a drug used to treat leukemia, typically costs $9,657 per month at retail and $120 per month with a voucher. In stark contrast, MCCPDC offers the same medication for just $47 per month. Similarly, the ulcerative colitis treatment Mesalamine, which has a retail price of $940 per month, is available for $32.40 through MCCPDC. The gout medication Colchicine, priced at $182 per month at retail, is offered for just $8.70.

The need for such an innovative approach is clear. According to a 2019 Kaiser Family Foundation survey, three in ten adults reported not taking their medications as prescribed due to cost concerns. A September 2021 Gallup poll revealed that 18 million Americans were recently unable to afford at least one prescription medication, and one in ten had skipped doses to save money. The launch of MCCPDC’s online pharmacy marks a significant milestone in the effort to make medications more affordable for millions of Americans.

Partnering with digital healthcare company Truepill, MCCPDC ensures a seamless, secure online patient experience. Truepill’s digital health platform powers the pharmacy’s website, while its nationwide pharmacy network handles prescription fulfillment and delivery, promising reliable service nationwide.

High drug prices have been a persistent problem in the United States, with government efforts to address the issue moving slowly and often proving ineffective. MCCPDC’s entrance into the market represents a bold attempt by the private sector to fill the gap, offering an alternative to the traditional, often costly, pharmaceutical model.

The Mark Cuban Cost Plus Drug Company’s mission extends beyond profit, reflecting its status as a public-benefit corporation. By charging a transparent, standard markup on all drugs, the company aligns its business goals with a broader social mission to improve public health. Launching its online pharmacy is just the beginning. It plans to expand its inventory of affordable generic drugs and complete the construction of a state-of-the-art pharmaceutical factory in Dallas by the end of 2025. With these initiatives, MCCPDC is poised to impact the pharmaceutical industry and provide much-needed relief to patients burdened by high medication costs.